Many observational epidemiologic studies have found an inverse association between alcohol consumption and hematological cancers (such as lymphoma and leukemia). This study, based on the Million Women's Study in the UK, is ...
Nov 13, 2012
0
0
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Nov 24, 2011
0
0
(Medical Xpress)—Researchers from UCLA's Jonsson Comprehensive Cancer Center have discovered that specific types of bacteria that live in the gut are major contributors to lymphoma, a cancer of the white blood cells.
Jul 16, 2013
1
0
(HealthDay)—Night shift work may increase the risk for chronic lymphocytic leukemia (CLL), according to a study published online Jan. 13 in Occupational & Environmental Medicine.
Jan 25, 2022
0
0
The scientific community has made great strides over the past decade in the development of a new class of cancer therapy called immunotherapy, a treatment that activates a patient's own immune system to target cancer cells. ...
Feb 14, 2019
0
38
Research led by the Department of Pathology at Stanford University, California, has found that chimeric antigen receptor T (CAR T) cell therapy can potentially result in a reactivation of human herpesvirus 6 (HHV-6) by CAR ...
A collaboration between the Griffith Institute for Drug Discovery (GRIDD) and multiple clinical research institutes has led to an exciting discovery in cancer research.
Nov 20, 2019
0
25
A seven-year-old yellow English Lab, Jake is a "big goofy guy with a giant smile," said his owner, Danielle Sweder of Marlborough, Mass. "He's always happy and loves to eat, play, and spread joy to others with his infectious ...
Oct 27, 2020
0
1
Cells of certain blood cancers such as Hodgkin's lymphoma carry the protein CD30 on their surface. The molecule is not only an indicator of a few cancers of the immune system but also increases the risk of their occurrence, ...
Apr 15, 2019
0
1
A novel immunotherapy appears safe for use in patients with a type of blood cancer called non-Hodgkin's lymphoma, according to a phase-1 multicenter clinical trial led by a researcher at the Stanford University School of ...
Oct 31, 2018
0
91
